medmix AG Statistics
Total Valuation
medmix AG has a market cap or net worth of CHF 409.52 million. The enterprise value is 642.42 million.
Market Cap | 409.52M |
Enterprise Value | 642.42M |
Important Dates
The next estimated earnings date is Wednesday, February 26, 2025.
Earnings Date | Feb 26, 2025 |
Ex-Dividend Date | Apr 26, 2024 |
Share Statistics
medmix AG has 40.79 million shares outstanding.
Shares Outstanding | 40.79M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.18% |
Owned by Institutions (%) | 28.80% |
Float | 23.99M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 16.00 |
PS Ratio | 0.88 |
PB Ratio | 0.89 |
P/FCF Ratio | 16.85 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.80, with an EV/FCF ratio of 26.44.
EV / Earnings | -356.90 |
EV / Sales | 1.34 |
EV / EBITDA | 8.80 |
EV / EBIT | 38.70 |
EV / FCF | 26.44 |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 77.34.
Current Ratio | 1.48 |
Quick Ratio | 1.03 |
Debt / Equity | 77.34 |
Debt / EBITDA | 4.98 |
Debt / FCF | 14.98 |
Interest Coverage | 1.39 |
Financial Efficiency
Return on equity (ROE) is -0.21% and return on invested capital (ROIC) is 1.27%.
Return on Equity (ROE) | -0.21% |
Return on Assets (ROA) | 1.03% |
Return on Capital (ROIC) | 1.27% |
Revenue Per Employee | 177,996 |
Profits Per Employee | -668 |
Employee Count | 2,695 |
Asset Turnover | 0.48 |
Inventory Turnover | 3.40 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.97% in the last 52 weeks. The beta is 0.79, so medmix AG's price volatility has been lower than the market average.
Beta (5Y) | 0.79 |
52-Week Price Change | -61.97% |
50-Day Moving Average | 12.13 |
200-Day Moving Average | 15.53 |
Relative Strength Index (RSI) | 32.29 |
Average Volume (20 Days) | 114,162 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, medmix AG had revenue of CHF 479.70 million and -1.80 million in losses. Loss per share was -0.04.
Revenue | 479.70M |
Gross Profit | 156.30M |
Operating Income | 16.60M |
Pretax Income | 500,000 |
Net Income | -1.80M |
EBITDA | 63.50M |
EBIT | 16.60M |
Loss Per Share | -0.04 |
Balance Sheet
The company has 140.70 million in cash and 363.90 million in debt, giving a net cash position of -223.20 million or -5.47 per share.
Cash & Cash Equivalents | 140.70M |
Total Debt | 363.90M |
Net Cash | -223.20M |
Net Cash Per Share | -5.47 |
Equity (Book Value) | 470.50M |
Book Value Per Share | 11.30 |
Working Capital | 105.60M |
Cash Flow
In the last 12 months, operating cash flow was 69.30 million and capital expenditures -45.00 million, giving a free cash flow of 24.30 million.
Operating Cash Flow | 69.30M |
Capital Expenditures | -45.00M |
Free Cash Flow | 24.30M |
FCF Per Share | 0.60 |
Margins
Gross margin is 32.58%, with operating and profit margins of 3.46% and -0.38%.
Gross Margin | 32.58% |
Operating Margin | 3.46% |
Pretax Margin | 0.10% |
Profit Margin | -0.38% |
EBITDA Margin | 13.24% |
EBIT Margin | 3.46% |
FCF Margin | 5.07% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 4.98%.
Dividend Per Share | 0.50 |
Dividend Yield | 4.98% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | 4.98% |
Earnings Yield | -0.42% |
FCF Yield | 5.93% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |